Skip to content
OpenCapital
Get started

Veracyte VCYT Shares Reserved for Future Issuance Under Stock Plans

Shares Reserved for Future Issuance Under Stock Plans at other companies

Guardant Health logo
Guardant HealthGH
——
Danaher logo
DanaherDHR
——

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$4.29B+10.7%

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0×0.0×
Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:CommonStockCapitalSharesReservedForFutureIssuance.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's shares reserved for future issuance under stock plans.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Veracyte's shares reserved for future issuance under stock plans?
Veracyte (VCYT) reported shares reserved for future issuance under stock plans of 16.1M in Q1 2026.
How has Veracyte's shares reserved for future issuance under stock plans changed year-over-year?
Veracyte's shares reserved for future issuance under stock plans increased by 6.2% year-over-year, from 15.2M to 16.1M.
What is the long-term trend for Veracyte's shares reserved for future issuance under stock plans?
Over 5 years (2020 to 2025), Veracyte's shares reserved for future issuance under stock plans has grown at a 11.9% compound annual growth rate (CAGR), from 9.5M to 16.6M.
What does shares reserved for future issuance under stock plans mean?
This represents the total number of common shares authorized and set aside for future issuance to employees and directors under equity compensation plans. It provides insight into the potential future dilution of existing shareholders. Investors monitor this to assess the firm's long-term incentive structure.